Partners

|   Location: Sydney, AU

Michelle is a Founding Partner and the Managing Partner at OneVentures. She serves on the investment committees of OneVentures funds and has led the capital raising activities for the firm. Her focus today is in the technology growth practice, though she has also worked extensively across both healthcare and technology investments.

With over 25 years of experience building and investing in high-growth technology companies in Australia and the US, she has a proven track record in global business expansion and Australian R&D. Michelle has led or co-led and been a Director of key investments in companies such as Employment Hero ($2B valuation, 13x ROI, Returned 1.5x Fund II), Phocas (10x EV growth), Smart Sparrow (acq. Pearson Learning), My Mobile Data (acq. ASX: AYS); Hatchtech (Lic. to NYSE: RDY) and unicorn Vaxxas. She chaired the board of Employment Hero until December 2023 and continues to serve on its board, as well as the boards of Phocas and Buildkite.

A current member of the Reserve Bank of Australia’s Payment Systems Board, Michelle is also a former board member of Australia’s National ICT Centre of Excellence (NICTA, now Data61), Seven West Media (ASX: SWM) and served on the NSW Government’s Digital Economy Taskforce.

In the lead up to founding OneVentures, Michelle worked for a leading family office on their alternative investments, served as an entrepreneur in residence at Southern Cross Venture Partners and was an angel investor.  Prior to her investment career, Michelle was a business entrepreneur and founder, including one of Australia’s first fintech companies, E Com Industries (www.giftvouchers.com) (acq. LSE: ReD, 4.6x, 70% IRR), IT services business, Networks Beyond 2000 and a tertiary tutoring business.

Michelle is a member of the Australian Institute of Company Directors and Chief Executive Women (CEW). She was a founding advisory board member of Head Over Heels (now Apropela), supporting women entrepreneurs, and served on the advisory board of the Indigenous fund Ochre Ventures.

In addition to these roles, she lectures in the Australian Investment Council’s Foundations of Private Capital Venture Capital Course and is a Co-Founder of WinVC, a non-profit women-led initiative supporting the career trajectory of women investors in venture capital.

Michelle holds a Bachelor of Science (Honours), a Master of Science and a PhD in Applied Science.

|   BSc(Hons), MSc, PhD 

|   Healthcare  

|   Location: Sydney, AU

Paul is a Founding Partner of OneVentures, leading the Healthcare and Biotechnology practice. He serves as Fund Lead and Chair of the Investment Committee for Healthcare Fund III and is a voting member of the Investment Committees for Funds I, II, III and V.

With over 30 years of experience in biomedical innovation, Paul provides strategic guidance to portfolio companies. He is Chair of Vaxxas and a Non-Executive Director for BiVACOR and Prota Therapeutics. Previously, he served on the boards of Hatchtech (Chair, licensed to NYSE: DRL), CharmHealth (acquired by ASX: CGL), Clinical Genomics (Enterix acquired by 3TM), Blade and Find Me.

As co-founder of Gemini Genomics (Nasdaq: GMNI), he led one of the UK’s largest biotech IPOs (US$250M valuation) before its merger with Sequenom (Nasdaq: SQNM). Earlier in his career, he co-founded Agamatrix, a bio-sensing medical device company operating in the US and Southeast Asia as well as Atomera (Nasdaq: ATMR). As CEO of Orchid Cellmark (Nasdaq: ORCH), he drove a tenfold valuation increase and significant revenue growth.

Paul began his career as a researcher and endocrinologist at St Vincent’s Hospital Sydney before transitioning into biotechnology. In the US, he held executive roles in leading biotech and medical companies driving the growth of several industry leaders.

He has authored over 100 publications in leading journals and is a Non-Executive Director at the Garvan Institute of Medical Research, a member of the UNSW Medicine Dean’s Advisory Group and serves on the Advisory Board of the Australian Government’s Australia’s Economic Accelerator (AEA) program.

Paul holds medical degrees from UNSW and is a Fellow of the Royal Australasian College of Physicians.

|   MBBS(Hons), MD, FRACP 

|   Growth Credit 

|   Location: Sydney, AU

|  BSc(Hons), AMCT

|   Healthcare

|   Location: Brisbane, AU

Sarah is a Partner at OneVentures, focused on sourcing and supporting life sciences companies developing transformative technologies with global potential.

She currently serves as Chair of Axial Therapeutics, a Board Member for Kira Biotech and an Alternate Board Member and Observer for Vaxxas, Clinical Genomics and Prota Therapeutics.

Sarah brings over 20 years of enterprise-level leadership experience across the life sciences ecosystem, from agriculture to healthcare. Her career spans start-ups, private and public companies (ASX- and NASDAQ-listed), multinational pharma, and university research organisations. She has a strong track record in deal-making, from early-stage investments and university collaborations to major pharma transactions worth hundreds of millions of dollars.

Prior to joining OneVentures, Sarah held roles in business development and commercial strategy in Australia and the United States, combining deep scientific expertise with commercial acumen to drive innovation to market.

Sarah holds a Bachelor of Agricultural Science with First Class Honours from the University of Queensland and a Master’s in Genomics from Cornell University. She has post-graduate training in negotiation from Harvard and is a Graduate of the Australian Institute of Company Directors (GAICD). She is also a member of the QIMR Berghofer Medical Research Institute Commercial Advisory Board and the AusBiotech Investment Advisory Group.

|   BAgrSc(Hons), M.P.S, GAICD

|   Growth Equity

|   Location: Sydney, AU

Bevin leads OneVentures’ growth technology investment strategy for Fund V and Fund VII and serves on their Investment Committees.

With over 20 years of experience in technology investing, M&A and capital markets, Bevin provides strategic guidance to portfolio companies and sits on the boards of Lumary and MyPass. He specialises in driving growth through acquisitions, organic expansion and operational excellence.

Before joining OneVentures, Bevin was a Partner at Bailador Technology Investments, where he led growth-stage technology investments across Australia and New Zealand. During his tenure, Bailador achieved nine successful exits, delivering over $250 million in returns at an average 3.1x CoC and 25% IRR. Key investments included Rezdy, RC TopCo, Standard Media Index and Updoc.

Prior to that, Bevin was Head of M&A at Catapult Group, where he led acquisitions that expanded the company’s scale and market presence globally and secured over $150 million in financing. Earlier in his career, he was a graduate analyst in corporate finance at Deloitte and a vice-president in investment banking at the Royal Bank of Scotland, advising emerging companies across capital markets and M&A.

Bevin graduated with a Master of Commerce from the University of Sydney and is a Member of the Australian Institute of Company Directors.

|   MCom, USYD BCom, USYD  

|   Growth Equity

|   Location: Sydney, AU

|   Location: Sydney, AU

Matt is a Partner and COO at OneVentures, where he leads legal, compliance, corporate finance, investor relations and marketing functions.

As General Counsel, Company Secretary and a Responsible Manager, Matt ensures regulatory excellence and robust governance. Matt also drives ESG practices across the portfolio, supporting founders and investors by implementing effective structures, aligning with industry standards and advancing sustainability goals.

With over 20 years of legal experience in financial services, he has held senior leadership roles both locally and internationally, including General Counsel & Company Secretary at Eclipx Group and Head of Legal, Compliance and Company Secretary at ING Bank Australia. His early career includes positions at Corrs Chambers Westgarth, Perpetual and Pitcher Partners.

Matt holds a Bachelor of Laws (LLB) and a Bachelor of Business (BBus) in Banking and Finance from QUT. Admitted to the Supreme Court of NSW and the High Court of Australia, he is also a Chartered Secretary and Public Notary.

|   LLB BBus Banking & Finance